In the in-house Chinese NSCLC cohort, NFE2L2/KEAP1 mutations significantly correlate with higher TMB value (P<0.0001 (Supplementary Figure 8D). This evidence concerns the gene NFE2L2 and non-small cell lung carcinoma.